By Jonathan Monk In times of crisis, we must never forget the power of human ingenuity. Some of the immense tragedies in history have been met with profound acts of innovation and creativity. As COVID-19 has rocked the modern business world and has forced companies to “pivot or perish.” While the cannabis industry has done […]
Coronavirus
Why You Shouldn’t Cut Your Marketing Budget During a Pandemic
It cannot be denied that the COVID-19 pandemic has touched every facet of our lives. To this end, in the year 2020, the business landscape has undergone violent upheavals, transitions, and changes. This notion is also true in the cannabis industry. As the coronavirus overtook the globe in spring 2020, business owners feared what such […]
How a Dispensary’s Financial Foundation Shined During COVID-19
COVID-19 pandemic wreaked havoc on everyone’s 2020 plans—and cannabis companies were no exception. As in-person interactions shrunk, for instance, some companies had to rapidly rethink how they operate or risk alienating customers or missing out on a new opportunity. Fortunately, for those companies that already had a solid foundation in place, they could quickly adapt […]
COVID-19’s Prolonged Impact on the Cannabis Industry
To say 2020 has thrown us a curve ball would be the understatement of the century. From growers, to producers and wholesalers, to retail sellers — the entire cannabis industry end-to-end has been impacted in some way by the COVID-19 pandemic. As we continue to pick up the pieces of the initial shock from back in […]
Mother’s Little Helper Is Back, and Daddy’s Partaking Too
After the kids go to bed, the grown-ups are drinking and smoking pot to distract themselves from the hellscape that is pandemic parenting. 7:51 p.m.: It’s exactly 125 days tomorrow. I am pretg drink. 7:52 p.m.: Drunk. 7:52 p.m. I can tell. 😂 I have a yearslong WhatsApp message group with a handful of fellow […]
Half of Cannabis Executives Slash Revenue Forecasts Due to Coronavirus, Reallocating Marketing Budgets to Digital Media and Virtual Events
New study quantifies the impact of COVID-19, with 56% of executives moving marketing spend to online events and digital media and 39% planning to scale-back staffing. Cannabis executives report slashing budgets and significant disruption to suppliers and services during the COVID-19 crisis, according to a new report published by Cannabis Business Executive (CBE) and cannabis […]
High stakes: How cannabis retailers can operate safely during and in the aftermath of coronavirus (COVID-19)
By Alison B. Torbitt, Staci Jennifer Riordan, Hillary Baca, Rachel L. Conn Cannabis companies, deemed essential businesses in many states, continue operating despite the COVID-19 pandemic. While many cannabis companies are struggling to stay open without eligibility for the Small Business Administration loans authorized by Congress, remaining operational has other considerations regarding how to revamp […]
Curating Consumer Insights for the Cannabis Industry
Amid the COVID-19 pandemic and the rising wave of mass demonstrations sparked by the tragic death of George Floyd, we felt it most appropriate to provide some broader perspectives on the latest consumer thinking during this chaotic time. To that end, we have looked beyond our latest analyses and that of our peers in the […]
Leadership and COVID-19: How to Lead Your Cannabis Business During a Crisis
Leading through a crisis situation like the COVID-19 pandemic is challenging in all industries, and the cannabis industry is no exception. From effectively meeting customers’ needs and generating revenue to keeping employees motivated, effective leadership is critical to keeping a cannabis business or ancillary business afloat. To be an effective leader during times of uncertainty […]
FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
PRESS RELEASE TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19, the […]
